![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/EIKO.png)
Share the post "Eiko Lifesciences Shareholding pattern FY(Q3-Dec 2024-2025)"
Shareholding results capture the distribution of ownership in a company as outlined in its financial disclosures. These results indicate the proportion of shares held by different investor categories and can reveal trends in market confidence. By studying shareholding results, investors and analysts can assess the influence of major shareholders on corporate governance and stock price movements. Eiko Lifesciences has released its latest shareholding reports, covering the third quarter and the fiscal year ending on (Q3-Dec 2024-2025).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
| Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares(in %) | Current Quarter Shares(in %) | Quarter to Quarter Difference |
|---|---|---|---|---|---|
| Promoters | 33.82 Lakh | 43.35 Lakh | 24.4 | 31.27 | +6.87 % |
| Public | 1.05 Cr | 95.26 Lakh | 75.6 | 68.73 | -6.87 % |
| DII | 0 | 0 | 0 | 0 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 |
| Government | 0 | 0 | 0 | 0 | 0 |
Promoters’ shareholding increased from 24.4% in September 2024-2025 to 31.27% in December 2024-2025. This rise indicates that the promoters have strengthened their control over Company during this period.The percentage of shares held by the public decreased from 75.6% in September 2024- to 68.73% in December 2024-.This reduction indicates that the public’s stake in the company diminished during this period.
Let’s look into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.
Below is a detailed table presenting the shareholding percentage of Promoters.
| Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
|---|---|---|---|---|---|
| LENUS FINVEST | 14.06 Lakh | 23.58 Lakh | 10.14 | 17.01 | + 6.87 % |
LENUS FINVEST has showcased a remarkable improvement in stakeholding for this quarter, registering a significant increase of 6.87 %.
Below is a detailed table showcasing the public shareholding percentage.
| Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
|---|---|---|---|---|---|
| Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 28.61 Lakh | 28.28 Lakh | 20.64 | 20.4 | -0.24 % |
| Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 39.38 Lakh | 34.05 Lakh | 28.41 | 24.57 | -3.84 % |
| SIVANESAN SELLAPPAN | 0 | 2.00 Lakh | 0 | 1.44 | +1.44% |
| JOYANTA KUMAR JANA | 2.75 Lakh | 2.75 Lakh | 1.98 | 1.99 | + 0.01 % |
| BHAVINKUMAR VINAYCHAND SHAH | 1.88 Lakh | 1.88 Lakh | 1.35 | 1.36 | + 0.01 % |
| ASHOK VISHWANATH HIREMATH | 12.33 Lakh | 5.33 Lakh | 8.9 | 3.85 | -5.05 % |
| Non Resident Indians (NRIs) | 2.38 Lakh | 1.83 Lakh | 1.71 | 1.32 | -0.39 % |
| Bodies Corporate | 30.70 Lakh | 26.95 Lakh | 22.15 | 19.45 | -2.7 % |
| 2B BLACK BIO LLP | 0 | 20.50 Lakh | 0 | 14.79 | +14.79% |
| Any Other (specify) | 3.21 Lakh | 3.65 Lakh | 2.32 | 2.63 | + 0.31 % |
| HUF | 3.19 Lakh | 3.64 Lakh | 2.3 | 2.63 | + 0.33 % |
| Clearing Members | 2.40 K | 694 | 0.02 | 0.01 | -0.01 % |
| V SQUARE PHARMACHEM . | 3.14 Lakh | 0 | 2.26 | 0 | -2.26% |
| 2B BLACK BIO LLP . | 20.50 Lakh | 0 | 14.79 | 0 | -14.79% |
Observations show a significant difference of -0.24 % in Resident Individuals holding nominal share capital up to Rs. 2 lakhs’s financial performance between quarters.Observations show a significant difference of -3.84 % in Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs’s financial performance between quarters.Leading the way to higher stakeholding, JOYANTA KUMAR JANA has significantly boosted stakeholding by an impressive 0.01 %.Leading the way to higher stakeholding, BHAVINKUMAR VINAYCHAND SHAH has significantly boosted stakeholding by an impressive 0.01 %.Observations show a significant difference of -5.05 % in ASHOK VISHWANATH HIREMATH’s financial performance between quarters.Observations show a significant difference of -0.39 % in Non Resident Indians (NRIs)’s financial performance between quarters.Observations show a significant difference of -2.7 % in Bodies Corporate’s financial performance between quarters.Leading the way to higher stakeholding, Any Other (specify) has significantly boosted stakeholding by an impressive 0.31 %.Leading the way to higher stakeholding, HUF has significantly boosted stakeholding by an impressive 0.33 %.Observations show a significant difference of -0.01 % in Clearing Members’s financial performance between quarters.SIVANESAN SELLAPPAN had no shares in the previous quarter but now holds 1.44% of shares in the current quarter.2B BLACK BIO LLP had no shares in the previous quarter but now holds 14.79% of shares in the current quarter.V SQUARE PHARMACHEM . had 2.26% of shares in the previous quarter but exited in the current quarter.2B BLACK BIO LLP . had 14.79% of shares in the previous quarter but exited in the current quarter.
[my_shortcode1 values=”Eiko Lifesciences”]
